NeuroOne Medical Technologies Corporation Increase (Decrease) in Accounts Payable and Accrued Liabilities
NeuroOne Medical Technologies Corporation (NMTC) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of $50.65 thousand for the 6-month period ending 2023-03-31, per its 10-Q filed 2023-05-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2023-05-12
- NeuroOne Medical Technologies Corporation increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2019-03-31 was -$383.26K, a 255.28% decline year-over-year.
- NeuroOne Medical Technologies Corporation increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2018-12-31 was $278.69K, a 62.86% increase year-over-year.
- NeuroOne Medical Technologies Corporation increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2018-03-31 was $246.82K, a 4415.59% increase year-over-year.
- NeuroOne Medical Technologies Corporation increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2017-12-31 was $171.12K.
- NeuroOne Medical Technologies Corporation increase (decrease) in accounts payable and accrued liabilities for fiscal 2015 was $3.69K, a 71.52% decline from fiscal 2014.
- NeuroOne Medical Technologies Corporation increase (decrease) in accounts payable and accrued liabilities for fiscal 2014 was $12.97K, a 787.47% increase from fiscal 2013.
- NeuroOne Medical Technologies Corporation increase (decrease) in accounts payable and accrued liabilities for fiscal 2013 was $1.46K, a 543.61% increase from fiscal 2012.
- NeuroOne Medical Technologies Corporation increase (decrease) in accounts payable and accrued liabilities for fiscal 2012 was $227.00.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 52 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 55 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 58 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 61 month |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-31 | $50.65K 10-Q · filed 2023-05-12 | ||||||||||
| 2019-03-31 | -$383.26K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-10 | -$104.58K 10-Q · filed 2019-05-10 | |||||||||
| 2018-12-31 | $278.69K 10-Q · filed 2019-02-14 | ||||||||||
| 2018-06-30 | $584.46K 10-Q · filed 2018-08-13 | ||||||||||
| 2018-03-31 | $246.82K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-10 | $417.94K 10-Q · filed 2019-05-10 | |||||||||
| 2017-12-31 | $171.12K 10-Q · filed 2019-02-14 | ||||||||||
| 2017-06-30 | $408.55K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | $414.02K 10-Q · filed 2018-08-13 | $20.80K 10-Q · filed 2017-08-14 | ||||||||
| 2017-03-31 | $5.47K 10-Q · filed 2017-05-22 | ||||||||||
| 2016-09-30 | -$5.66K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-21 | -$61.00 derived: sum of 2 quarters · filed 2017-08-14 | $4.63K 10-Q · filed 2016-11-21 | $10.18K derived: sum of 4 quarters · filed 2017-08-14 | |||||||
| 2016-06-30 | $5.60K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $10.28K 10-Q · filed 2017-08-14 | $15.84K derived: sum of 3 quarters · filed 2017-08-14 | $24.87K derived: sum of 4 quarters · filed 2017-08-14 | |||||||
| 2016-03-31 | $4.69K 10-Q · filed 2017-05-22 | -$1.02K 10-Q · filed 2016-05-23 | $10.24K derived: sum of 2 quarters · filed 2017-05-22 | $19.27K derived: sum of 3 quarters · filed 2017-05-22 | $18.22K derived: sum of 4 quarters · filed 2017-05-22 | ||||||
| 2015-12-31 | $5.56K derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-14 | $14.59K derived: sum of 2 quarters · filed 2016-11-21 | $13.53K derived: sum of 3 quarters · filed 2016-11-21 | $3.69K 10-K · filed 2016-04-14 | |||||||
| 2015-09-30 | $9.03K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-21 | $7.97K derived: sum of 2 quarters · filed 2016-11-21 | -$1.86K 10-Q · filed 2016-11-21 | -$4.70K 10-Q · filed 2015-11-16 | $2.21K derived: sum of 4 quarters · filed 2016-11-21 | ||||||
| 2015-06-30 | -$1.06K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-19 | -$10.89K 10-Q · filed 2016-08-19 | -$4.21K 10-Q · filed 2015-08-13 | -$6.82K derived: sum of 3 quarters · filed 2016-08-19 | -$9.63K derived: sum of 4 quarters · filed 2016-08-19 | ||||||
| 2015-03-31 | -$9.84K 10-Q · filed 2016-05-23 | -$5.76K derived: sum of 2 quarters · filed 2016-05-23 | -$8.57K derived: sum of 3 quarters · filed 2016-05-23 | -$1.07K derived: sum of 4 quarters · filed 2016-05-23 | |||||||
| 2014-12-31 | $4.07K derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-14 | $1.26K derived: sum of 2 quarters · filed 2016-04-14 | $8.76K derived: sum of 3 quarters · filed 2016-04-14 | $12.97K 10-K · filed 2016-04-14 | |||||||
| 2014-09-30 | -$2.81K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-16 | $4.69K derived: sum of 2 quarters · filed 2015-11-16 | $8.89K 10-Q · filed 2015-11-16 | $9.30K derived: sum of 4 quarters · filed 2015-11-16 | $11.71K 10-Q · filed 2014-11-19 | ||||||
| 2014-06-30 | $7.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $11.70K 10-Q · filed 2015-08-13 | $12.11K derived: sum of 3 quarters · filed 2015-08-13 | $12.51K derived: sum of 4 quarters · filed 2015-08-13 | $13.57K 10-Q · filed 2014-08-18 | ||||||
| 2014-03-31 | $4.20K 10-Q · filed 2015-05-20 | $4.61K derived: sum of 2 quarters · filed 2015-05-20 | $5.01K derived: sum of 3 quarters · filed 2015-05-20 | $5.34K derived: sum of 4 quarters · filed 2015-05-20 | $6.07K 10-Q · filed 2014-05-20 | ||||||
| 2013-12-31 | $410.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2014-04-24 | $811.00 derived: sum of 2 quarters · filed 2014-11-19 | $1.14K derived: sum of 3 quarters · filed 2014-11-19 | $1.46K 10-K/A · filed 2014-04-24 | $1.86K 10-K/A · filed 2014-04-24 | ||||||
| 2013-09-30 | $401.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-19 | $728.00 derived: sum of 2 quarters · filed 2014-11-19 | $1.05K 10-Q · filed 2014-11-19 | ||||||||
| 2013-06-30 | $327.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-18 | $650.00 10-Q · filed 2014-08-18 | |||||||||
| 2013-03-31 | $323.00 10-Q · filed 2014-05-20 | ||||||||||
| 2012-12-31 | $227.00 10-K/A · filed 2014-04-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B |